- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00576719
Effectiveness of Intensive Cognitive Behavioral Therapy in Treating Adolescent Panic Disorder and Agoraphobia
Intensive Treatment of Adolescent Panic and Agoraphobia
Study Overview
Status
Conditions
Detailed Description
Panic disorder (PD) in adolescents is a prevalent and chronic anxiety disorder. People with PD experience unexpected attacks of fear, along with elevated heart rate, dizziness, faintness, weakness, and increased sweating. During these panic attacks, people may feel numbness in their hands, flushed or chilled, nauseous, or pain in the chest, and they may lose touch with reality. PD can lead to substantial social impairment for adolescents, including avoidance of school, independent activities, and peer involvement. When PD progresses so far that a person avoids public places where a panic attack might occur, the person is said to have a condition known as agoraphobia. Weekly sessions of cognitive behavioral therapy (CBT) appear to be effective in treating panic disorder with agoraphobia (PDA). However, many adolescents with PDA and their families report the need for a more immediate relief from the disorder. This study will evaluate the effectiveness of intensive CBT in treating adolescents with PDA.
Participants in this single blind study will be randomly assigned to one of three conditions: intensive CBT treatment including family members, intensive CBT treatment without family members, or a waitlist control group. All participants in the intensive CBT treatment groups will undergo 8 days of intensive CBT, for a total of 6 sessions. On Days 1 through 3 of treatment, participants will attend daily, 2-hour CBT sessions. The CBT sessions will include psychoeducation about anxiety, tactics to restructure anxiety-provoking thoughts, and exposure to bodily sensations that trigger panic. On Days 4 and 5, participants will meet with a therapist to learn ways to approach previously feared situations. On Days 6 and 7, participants will continue working independently or with family members to solidify skills. On Day 8, participants will attend a final 2-hour session to consolidate skills, review the independent weekend activities, and discuss ways to apply skills to the home environment. Parents of participants in the parental involvement group will attend the last 30 minutes of sessions, complete homework assignments, learn ways to coach their children through episodes, and participate in selected exposures. After 6 weeks of waitlist, participants in the waitlist control group will receive active treatment following the same procedures as the initial active treatment. All participants will be assessed at Months 3, 6, and 12 post-treatment.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Boston University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Meets DSM-IV criteria for principal diagnosis of PD or PDA prior to treatment
- Adolescent must be accompanied by at least one parent or caregiver
- If on medication, there must be a 1-month stabilization period for benzodiazepines or 3-month stabilization period for SSRIs or tricyclics prior to study entry
Exclusion Criteria:
- Positive diagnosis of schizophrenia, pervasive developmental disorder, organic brain syndrome, mental retardation, or current suicidal ideation
- Unavailability of at least one parent or caregiver
- Refusal of parent to accept random assignment to treatment condition
- Refusal of parent or adolescent to accept stabilization of medication
- Adolescent with parent who has any condition that would limit ability to understand treatment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
Participants will receive intensive cognitive behavioral therapy treatment without parent involvement
|
Intensive panic control treatment without parent involvement is an 8-day, intensive form of cognitive behavioral therapy (CBT) with exposure, including 15-20 hours of direct therapist contact.
The basic treatment components are psychoeducation about anxiety, restructuring anxiety-provoking thoughts, exposure to bodily sensations that trigger panic, and in vivo exposures.
|
Experimental: 2
Participants will receive intensive cognitive behavioral therapy treatment with parent involvement
|
Intensive panic control treatment with parent involvement involves the same form of intensive CBT, but with direct parent involvement.
Parents will attend the last 30 minutes of didactic sessions, complete homework assignments, learn ways to coach their children, and participate in selected exposures.
|
Placebo Comparator: 3
Waitlist control group
|
Waitlist control participants will receive active treatment (treatment with or without family involvement) after 6 weeks of waitlist.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Anxiety Disorders Interview Schedule-Child and Parent Versions: Clinical Severity Rating, Agoraphobia Ratings, Panic Attack Frequency Scores, and Internal Sensation Anxiety Ratings
Time Frame: Measured at Months 3, 6, and 12 post-treatment
|
Measured at Months 3, 6, and 12 post-treatment
|
Panic Disorder Severity Scale-Child Version
Time Frame: Measured at Months 3, 6, and 12 post-treatment
|
Measured at Months 3, 6, and 12 post-treatment
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Multidimensional Anxiety Scale for Children
Time Frame: Measured at Months 3, 6, and 12 post-treatment
|
Measured at Months 3, 6, and 12 post-treatment
|
Childhood Anxiety Sensitivity Index
Time Frame: Measured at Months 3, 6, and 12 post-treatment
|
Measured at Months 3, 6, and 12 post-treatment
|
Fear and Avoidance Hierarchy
Time Frame: Measured at Months 3, 6, and 12 post-treatment
|
Measured at Months 3, 6, and 12 post-treatment
|
Children's Depression Inventory
Time Frame: Measured at Months 3, 6, and 12 post-treatment
|
Measured at Months 3, 6, and 12 post-treatment
|
The Panic Attack Record
Time Frame: Measured at Months 3, 6, and 12 post-treatment
|
Measured at Months 3, 6, and 12 post-treatment
|
Subjective Symptoms Scale
Time Frame: Measured at Months 3, 6, and 12 post-treatment
|
Measured at Months 3, 6, and 12 post-treatment
|
Panic and Phobia Questionnaire
Time Frame: Measured at Months 3, 6, and 12 post-treatment
|
Measured at Months 3, 6, and 12 post-treatment
|
Participant Global Impression of Improvement (PGI)
Time Frame: Measured at Months 3, 6, and 12 post-treatment
|
Measured at Months 3, 6, and 12 post-treatment
|
Perceptions of Treatment Questionnaire: Adolescent and Parent Versions
Time Frame: Measured at Months 3, 6, and 12 post-treatment
|
Measured at Months 3, 6, and 12 post-treatment
|
Children's Perception Scale (Locus of Control Scale)
Time Frame: Measured at Months 3, 6, and 12 post-treatment
|
Measured at Months 3, 6, and 12 post-treatment
|
Child Behavior Checklist (CBCL)
Time Frame: Measured at Months 3, 6, and 12 post-treatment
|
Measured at Months 3, 6, and 12 post-treatment
|
Stress Index for Parents of Adolescents
Time Frame: Measured at Months 3, 6, and 12 post-treatment
|
Measured at Months 3, 6, and 12 post-treatment
|
Parenting Locus of Control Scale
Time Frame: Measured at Months 3, 6, and 12 post-treatment
|
Measured at Months 3, 6, and 12 post-treatment
|
Therapy Attitude Inventory
Time Frame: Measured at Months 3, 6, and 12 post-treatment
|
Measured at Months 3, 6, and 12 post-treatment
|
Family Assessment Measure (FAM)
Time Frame: Measured at Months 3, 6, and 12 post-treatment
|
Measured at Months 3, 6, and 12 post-treatment
|
Depression Anxiety and Stress Scale (DASS)
Time Frame: Measured at Months 3, 6, and 12 post-treatment
|
Measured at Months 3, 6, and 12 post-treatment
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Donna Pincus, PhD, Boston University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01MH068277 (U.S. NIH Grant/Contract)
- DSIR 84-CTS (Division of Services and Intervention Research)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Panic Disorder
-
Philipps University Marburg Medical CenterGerman Federal Ministry of Education and ResearchCompletedPanic Disorder With Agoraphobia | Panic Disorder Without AgoraphobiaGermany
-
Ulrike WillutzkiUnknownDepression | Panic Disorder | Agoraphobia | Panic Disorder With Agoraphobia | Agoraphobia With Panic AttacksGermany
-
Beth Israel Medical CenterTerminatedPanic Disorder | Major Depressive Disorder With Panic AttacksUnited States
-
Charite University, Berlin, GermanyRecruitingGeneralized Anxiety Disorder | Social Anxiety Disorder | Panic Disorder With Agoraphobia | Panic Disorder Without AgoraphobiaGermany
-
Southern Methodist UniversityBoston University; University of MichiganCompletedPanic Disorder With AgoraphobiaUnited States
-
Karolinska InstitutetCompleted
-
Region SkaneCompletedPanic Disorder (With or Without Agoraphobia)Sweden
-
Michael E. DeBakey VA Medical CenterSouth Central VA Mental Illness Research, Education & Clinical CenterUnknown
-
Beth Israel Medical CenterCompletedPanic Disorder | Major Depression With Panic AttacksUnited States
-
Ruhr University of BochumTerminatedPanic Disorder With AgoraphobiaGermany
Clinical Trials on Intensive panic control treatment without parent involvement
-
Michael E. DeBakey VA Medical CenterUnknownPanic DisorderUnited States
-
The Miriam HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
Michael E. DeBakey VA Medical CenterSouth Central VA Mental Illness Research, Education & Clinical CenterUnknown
-
Region SkaneCompletedPanic Disorder (With or Without Agoraphobia)Sweden
-
Weill Medical College of Cornell UniversityNational Institute of Mental Health (NIMH)CompletedAnxiety Disorders | Panic Disorder | AgoraphobiaUnited States
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)Completed
-
Boston UniversityNational Institute of Mental Health (NIMH)CompletedPanic DisorderUnited States
-
University College, LondonCompletedPeriodontitis | Intimal Medial Thickness of Internal Carotid ArteryUnited Kingdom
-
Arizona State UniversityCompletedDietary Added Sugar ConsumptionUnited States
-
Maastricht University Medical CenterDutch Health Care Insurance Board (nr: 00106), Amstelveen, The NetherlandsCompleted